Fulvestrant

Brand: Faslodex (global)

Endocrine SERD

Chemistry

Molecular Formula	C32H47F5O3S
PubChem	CID: 104741 Open in PubChem

Structure

Half-life	40 days
Clearance Route	hepatic
Active Metabolites	no
Notes	IM monthly dosing; not daily mg concept; long half-life ~40 days.

Severity: Moderate

Adverse Effects:
Injection site pain, liver enzyme elevation, hot flashes

Contraindications:
Severe hepatic impairment

Precautions:
Monitor LFTs; avoid pregnancy